Literature DB >> 24559786

Prognostic significance of an elevated neutrophil-lymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia.

José A González-Fajardo1, José A Brizuela-Sanz2, Beatriz Aguirre-Gervás3, Borja Merino-Díaz2, Lourdes Del Río-Solá2, Miguel Martín-Pedrosa2, Carlos Vaquero-Puerta2.   

Abstract

BACKGROUND: The aim of this study was to investigate the utility of admission neutrophil-lymphocyte ratio (NLR) in predicting the amputation-free survival (AFS) of patients with critical limb ischemia (CLI) who underwent an elective infrainguinal therapeutic intervention.
METHODS: All patients with CLI undergoing elective infrainguinal vascular surgery (open or endovascular) at a single university teaching hospital between January 2005 and December 2009 were retrospectively identified from a prospectively maintained database. The primary end point was AFS. The cut-off of NLR >5 was used to categorize patients into low- and high-NLR groups. Kaplan-Meier analysis and long-rank test were used to compare survival between both groups. Cox regression analysis was conducted to determine independent factors affecting the AFS.
RESULTS: During a median follow-up of 31 months, 561 patients with chronic CLI underwent infrainguinal revascularization. Five-year mortality was lower in the NLR <5 group (33%) than in the NLR >5 group (49%) (P ≤ 0.001), and the AFS was significantly higher in the NLR <5 group (50%) than in the NLR >5 group (26%) (P ≤ 0.001). In a multivariate analysis, preoperative NLR >5 was independently associated with 5-year AFS (hazard ratio 2.325, 95% CI 1.732-3.121).
CONCLUSIONS: Elevated NLR predicts a worse AFS in patients undergoing infrainguinal vascular revascularization with chronic CLI, suggesting that the NLR conveys powerful prognostic information that is independent of other conventional clinical risk factors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24559786     DOI: 10.1016/j.avsg.2013.06.037

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  15 in total

1.  Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing.

Authors:  Nasibeh Vatankhah; Younes Jahangiri; Gregory J Landry; Robert B McLafferty; Nabil J Alkayed; Gregory L Moneta; Amir F Azarbal
Journal:  J Vasc Surg       Date:  2016-11-23       Impact factor: 4.268

2.  Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation.

Authors:  Han Luo; Ding Yuan; Hongliu Yang; Ma Yukui; Bin Huang; Yi Yang; Fei Xiong; Guojun Zeng; Zhoupeng Wu; Xiyang Chen; Tiehao Wang; Hailong Luo; Jichun Zhao
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

3.  Neutrophil-to-lymphocyte ratio is effective prognostic indicator for post-amputation patients with critical limb ischemia.

Authors:  Qi Wang; Han Liu; Siqiao Sun; Zhihua Cheng; Yang Zhang; Xiwei Sun; Zhongying Wang; Shuai Wang
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

4.  High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients.

Authors:  Han Li; Xiangxue Lu; Ruifang Xiong; Shixiang Wang
Journal:  Mediators Inflamm       Date:  2017-02-21       Impact factor: 4.711

5.  Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy.

Authors:  Ying Bi; Jing Shen; Sheng-Cai Chen; Ji-Xiang Chen; Yuan-Peng Xia
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

Review 6.  Cell Therapy in Patients with Critical Limb Ischemia.

Authors:  Rita Compagna; Bruno Amato; Salvatore Massa; Maurizio Amato; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

7.  What is the clinical benefit of neutrophil-lymphocyte ratio in cardiovascular patients?

Authors:  Yavuzer Koza
Journal:  J Cardiovasc Thorac Res       Date:  2014-06-30

Review 8.  The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease.

Authors:  Feliciano Chanana Paquissi
Journal:  Ther Clin Risk Manag       Date:  2016-05-27       Impact factor: 2.423

9.  Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE).

Authors:  Marwa Sayed Meshaal; Abdo Nagi; Ahmed Eldamaty; Wae'el Elnaggar; Mervat Gaber; Hussien Rizk
Journal:  Egypt Heart J       Date:  2019-09-18

Review 10.  The Role of Circulating Biomarkers in Peripheral Arterial Disease.

Authors:  Goren Saenz-Pipaon; Esther Martinez-Aguilar; Josune Orbe; Arantxa González Miqueo; Leopoldo Fernandez-Alonso; Jose Antonio Paramo; Carmen Roncal
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.